Sage Journals: Discover world-class research

Retricted access

Announcement

First published 2007-11

Systemic Bevacizumab for Retinal Angiomatous Proliferation Associated with Retinal Pigment Epithelial Detachment

N. Abi-Ayad, M. Mauget-Faÿsse, S. Amara-Allieu [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2012-3

Aggravated capillary non-perfusion after intravitreal bevacizumab for macular edema secondary to systemic lupus erythematosus and anti-phospholipid syndrome

S Jeon, WK Lee

Lupus

Retricted access

Research article

First published 2011-11

Systemic Bevacizumab (Avastin) for Exudative Retinal Detachment Secondary to Choroidal Melanoma

Hadas Newman, Paul T. Finger, Kimberly J. Chin [...]

European Journal of Ophthalmology

Retricted access

Research article

First published 2025-1

Improvement in Cystoid Macular Edema Secondary to Systemic Bevacizumab in a Patient With Coats Plus Syndrome

Saima Khan, Cole A. Martin, Shannon Scarboro [...]

Journal of VitreoRetinal Diseases

Open access

Research article

First published 2022

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Tiago de Castro, Leonie S. Jochheim, Melanie Bathon [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024-2

Recurrent Respiratory Papillomatosis With Complete Response to Systemic Bevacizumab Therapy

Daniel Gorelik, Amy Frantz, Jeffrey S. Dome [...]

Ear,Nose & Throat Journal

Open access

Review article

First published 2025-04

Prognostic Biomarkers for Hepatocellular Carcinoma Patients Treated With Atezolizumab plus Bevacizumab Combination Therapy

Long-Bin Jeng, Horng-Ren Yang, Chiao-Fang Teng

Cancer Control

Open access

Case report

First published 2024-1

Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis

Cal H. Robinson, Michael Hart-Matyas, Daniel A. Morgenstern [...]

Annals of Otology,Rhinology & Laryngology

Retricted access

Letter

First published 2019-2

Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies

Hanny Al-Samkari

Otolaryngology–Head and Neck Surgery

Retricted access

Letter

First published 2019-2

Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies”

Yuan-Pin Hsu, Chin-Wang Hsu, Chiehfeng Chen

Otolaryngology–Head and Neck Surgery

Search results